HUMACYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.27 USD | -0.68% |
|
-2.81% | +155.99% |
| 06-03 | Humacyte Insider Sold Shares Worth $1,561,605, According to a Recent SEC Filing | MT |
| 05-30 | Certain Common Stock of Humacyte, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 866M | - | - | - | - | - | |
| 57.87B | - | |||||
| 40.25B | ||||||
| 39.94B | ||||||
| 28.54B | ||||||
| 26.4B |
- Stock Market
- Equities
- HUMA Stock
- Charts Humacyte, Inc.
- Sector Chart
